• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number QC-3-8-3D
Medical Device Problem Code Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/25/2022
Type of Reportable Event Malfunction
Event or Problem Description
Medtronic received a report that there was great resistance of both coils and they were stuck in the sheath and couldn't come out. the reported devices and any accessory devices were prepared as indicated in the ifu.No patient symptoms or further complications were reported as a result of this event.  the patient was undergoing surgery for treatment of which was unknown.It was noted the patient's blood flow was normal and vessel tortuosity was normal.Additional information received reported during preparation, the introducer sheath was held vertically when the implant coil was pulled back inside during hydration.
 
Additional Manufacturer Narrative
Product analysis #(b)(4):equipment used: vis (b)(4), m-203cm ruler (b)(4), pin gauges (b)(4) & (b)(4) document used: (b)(4) rev.B, (b)(4)doc rev.C, (b)(4) rev.E as found condition (condition of returned device): the axium implant coil was returned for analysis within a shipping box; returned within a sealed plastic biohazard pouch; returned within an open axium implant coil inner pouch and within a dispenser coil.Damage location details: the axium implant coil was returned within the introducer sheath which was found to be applied correctly with the wavelock facing towards the proximal end, however the introducer sheath was found to have traces of dried blood at both proximal and distal end.The axium implant coil pushwire was found to be bent at ~7.5cm from the proximal end.The axium implant coil was found to be damaged within the introducer sheath.The axium implant coil was found to have a damage and missing the distal tip within the introducer sheath.The implant coil was not able to be pushed out of introducer sheath due to resistance encountered within the introducer sheath.No other anomalies were observed.Testing/analysis (including sem reports): the axium implant coil tip od (outer diameter) which was unable to measure due to the damage found with the distal tip.The introducer sheath id (inner diameter) which was measured to be 0.19¿ (0.48mm) which was found to be within specification (specification 0.47mm +0.03mm /-0.00mm).Conclusion: based on the device analysis and the reported information, the customer¿s report of ¿coil resistance/stuck in sheath¿ was confirmed.There were no reported issues preparing the axium implant coil prior to use per the instructions for use (ifu).Therefore, it is likely that the axium implant coil became damaged during preparation, or due to an improper hubbing technique (over tightening of the rhv).Another possible cause for the resistance may have been from the blood found within the introducer sheath which may have been caused from not properly flushing the device correctly.Regarding the damage found with the pushwire damage can occur if the device is advanced against resistance or due to handling.However, the root cause for resistance nor the root cause for the axium implant coil damage could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM 3D
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key16035209
Report Number2029214-2022-02164
Device Sequence Number7225050
Product Code KRD
UDI-Device Identifier00847536037700
UDI-Public00847536037700
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K081465
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 01/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/23/2025
Device Model NumberQC-3-8-3D
Device Catalogue NumberQC-3-8-3D
Device Lot Number224405850
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/17/2022
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/15/2022
Supplement Date Received by Manufacturer01/10/2023
Initial Report FDA Received Date12/22/2022
Supplement Report FDA Received Date01/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/23/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-